Presentation of the Centre

MSCI - founded in 1932 as the Radium Institute by double Nobel Prize laureate Maria Sklodowska-Curie in collaboration with the Polish Government - is a modern comprehensive cancer centre and a governmental research institute involved in basic/preclinical research, clinical trials, diagnostic and treatment, and education in oncology.

It involves several facilities located in Warszawa, Gliwice, and Krakow and provides care to patients from the whole country.

Since 2020, MSCI was awarded the role of the National Research Institute, being a leader of the National Cancer Strategy and the National Oncology Network. MSCI is also the National Coordinating Center for population screening and primary cancer prevention and runs the National Cancer Registry.

Main Research Activities

The main research activities are based on close collaboration with on-site basic science departments and cancer-orientated clinical wards. The repository of tissues and medical data of cancer patients offers unique research opportunities.

MSCI is experienced in:

• a multidisciplinary approach; applying highly specialised procedures (70% of patients receive the combined treatment), monitoring any complications and unwanted side effects of treatment.
• complex diagnostic facilities, including molecular biology, genetics and proteomics, and Center of Excellence for Precision Oncology
• direct clinical application of ongoing research.
• conducting clinical trials (non-commercial trials in cooperation with EORTC and the Polish Medical Research Agency, and commercial – in total about 500 clinical trials only in oncology).
• Cooperation with Patients Advocacy Groups

Core Facilities

The clinical part is located in a 10-floor building, where each floor is a separate cancer-specific department with a multidisciplinary team providing comprehensive care for cancer patients (surgery, radiotherapy, systemic treatment, psychotherapy and physiotherapy). In addition, there are Day Care Centers, Outpatient Clinics and the Cancer Prevention Centre (involved in many international projects, e.g. the Nordic-European Initiative on Colorectal Cancer, European Polyp Surveillance Trial and Era-NET Transcan), the Center for Research and Development, the Early-Phase Clinical Trials Unit, the Hyperthermia Department, The Centre for Excellence in Precision Oncology, and CART Facility (under development).

Presentation of the Centre

The Greater Poland Cancer Centre (GPCC) is one of the largest comprehensive cancer centres in Poland and Europe. Supervised by the Greater Poland Voivodeship authorities, it provides advanced oncological care, hospitalising over 33,300 patients annually. Each year, the Centre performs approximately 7,000 surgical procedures, 7,000 radiotherapy treatments, and handles nearly 168,000 outpatient visits (as of 2024). GPCC operates across three locations: its main site in Poznań and branches in Kalisz and Piła. These modern facilities offer a full spectrum of radiation oncology services, including diagnostics, treatment, and research.

Staff

At GPCC, we prioritise professional excellence. Most wards and departments are led by university professors, while many of our physicians hold doctoral degrees and multiple specialisations. Half of our nursing staff have university degrees, with many holding specialist licences. Our diagnostic and therapeutic teams also include psychologists, medical physicists, physiotherapists, biologists, and laboratory diagnosticians.

Science at GPCC

GPCC is accredited for residency programmes in multiple oncological and surgical fields. It hosts four university departments: Biotechnology (Prof. A. Mackiewicz), Cancer Pathology and Prophylactics (Prof. A. Marszałek), Head and Neck Surgery (Prof. W. Golusiński), and Electroradiology (Prof. J. Malicki). The Centre is also home to the editorial offices of four international scientific journals: Reports of Practical Oncology and Radiotherapy, Letters in Oncology Science, Contemporary Oncology, and Journal of Contemporary Brachytherapy.